Our Pricing

How to Use Your Mounjaro Discount Code in the UK

Searching for a valid mounjaro discount code uk to reduce your prescription costs? At Cured Pharmacy, new patients can access Mounjaro weight loss injections from £135.00 using code WEIGHTLOSSNEW, with transparent upfront pricing and a free clinical consultation from UK-registered prescribers. All Mounjaro prescriptions are subject to clinical assessment and approval by our qualified healthcare team.

Understanding Mounjaro Pricing and Your Discount Code

Mounjaro (tirzepatide) pricing varies significantly across UK pharmacies, with monthly costs often creating barriers to accessing this effective weight management treatment. At Cured Pharmacy, we've structured our pricing to ensure transparency before you complete your consultation, with new patients eligible for our introductory offer using discount code WEIGHTLOSSNEW at checkout.

The active ingredient tirzepatide is a dual GIP/GLP-1 receptor agonist, representing a newer class of medication than traditional single-pathway treatments [1]. Your final prescription dose and duration will be determined by your UK prescriber based on your medical history, current medications, and weight management goals during the free online consultation.

Unlike some online providers, we display exact pricing before you begin your assessment, ensuring no hidden fees or unexpected charges. All consultations are conducted by GPhC-registered prescribers, and every medication is dispensed from our UK-registered pharmacy under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

How Mounjaro Works for Weight Management

Mounjaro contains tirzepatide, which activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously [1]. This dual mechanism enhances insulin secretion when blood glucose is elevated, slows gastric emptying to promote satiety, and reduces appetite through central nervous system pathways.

Clinical trial data demonstrates substantial efficacy: in the SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. The SURPASS clinical programme further established tirzepatide's effectiveness across diverse patient populations, with consistent results in both metabolic and weight management outcomes [2].

The medication is administered as a once-weekly subcutaneous injection using the KwikPen device, which features a pre-filled, single-dose format designed for ease of use. Treatment typically begins at a lower dose (2.5mg) with gradual titration every four weeks, allowing your body to adjust and minimising potential gastrointestinal side effects commonly associated with GLP-1 receptor agonists.

Expected Timeline and Results

Most patients begin noticing appetite reduction within the first two weeks of treatment, though significant weight changes typically become apparent after 8-12 weeks of consistent use [1]. Clinical trials measured outcomes over 72 weeks, demonstrating that sustained treatment produces progressive results rather than immediate dramatic changes.

Your UK prescriber will schedule regular review consultations to monitor your progress, adjust dosing as clinically appropriate, and assess for any side effects or contraindications. Weight management with Mounjaro works best when combined with dietary modifications and increased physical activity, as recommended in NICE guidance for obesity management.

Mounjaro vs Alternative Weight Loss Treatments

Several prescription weight management medications are licensed in the UK, each with distinct mechanisms, efficacy profiles, and administration methods. Understanding these differences helps you and your prescriber select the most appropriate treatment for your individual circumstances.

Wegovy contains semaglutide, a selective GLP-1 receptor agonist that operates through a single pathway rather than tirzepatide's dual mechanism. Head-to-head trial data suggests tirzepatide produces greater average weight reduction, though both medications demonstrate clinically significant efficacy when compared to placebo [2][3]. Wegovy is also administered weekly via injection and follows a similar dose-escalation protocol.

Saxenda uses liraglutide, an earlier-generation GLP-1 agonist requiring daily injections rather than weekly administration. While effective for many patients, clinical trials show more modest weight reduction compared to newer agents like tirzepatide and semaglutide [3]. For patients preferring oral medications, options include Orlistat-based treatments, which work by reducing dietary fat absorption rather than affecting appetite hormones.

Choosing Between Injectable and Oral Options

Injectable GLP-1 receptor agonists generally demonstrate superior weight reduction in clinical trials compared to oral alternatives, though patient preference and lifestyle factors play important roles in treatment adherence. Some patients find weekly injections more convenient than daily tablets, while others prefer non-injectable options despite potentially lower efficacy.

Your prescriber will discuss your preferences, previous treatment experiences, and any needle phobia or injection-site concerns during your consultation. All prescription weight management medications available through Cured Pharmacy require ongoing clinical monitoring and are intended as adjuncts to lifestyle modification rather than standalone solutions.

Applying Your Mounjaro Discount Code at Checkout

Redeeming your discount code is straightforward: after completing your free online consultation and receiving prescriber approval, you'll proceed to the secure checkout page where a clearly marked discount code field appears. Enter WEIGHTLOSSNEW exactly as shown (case-sensitive), and the discount will be applied automatically before payment.

The consultation itself takes under three minutes for most patients and covers essential medical history including current medications, allergies, cardiovascular health, and previous weight management attempts. Our UK prescribers review every submission individually—there are no automated approvals—ensuring clinical safety and appropriateness before any prescription is issued.

If your prescriber determines Mounjaro is not suitable based on your medical history or current health status, they may recommend alternative treatments or suggest consulting your NHS GP for further evaluation. This clinical gatekeeping ensures patient safety and compliance with MHRA prescribing guidelines for prescription-only medications.

Delivery, Storage, and Administration Guidance

Once your prescription is approved and dispensed, medications are shipped in discreet, unmarked packaging via tracked courier services. Mounjaro pens require refrigeration between 2°C and 8°C until first use, after which they may be stored at room temperature (up to 30°C) for up to 21 days if needed for travel or convenience.

Each KwikPen is pre-filled with a single dose and includes a hidden needle that automatically inserts and retracts, minimising injection anxiety for patients new to subcutaneous medications. The injection is administered into the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipodystrophy or injection-site reactions.

Detailed administration instructions are included with every prescription, and our pharmacy team remains available via phone during business hours for any questions about storage, injection technique, or managing potential side effects. Never share pens between individuals, even family members, due to infection risk and dosing safety concerns.

Managing Common Side Effects

Gastrointestinal symptoms including nausea, diarrhoea, and constipation are the most frequently reported side effects, typically most pronounced during the initial weeks and dose-escalation phases [1]. These effects often diminish as your body adjusts, and can be minimised by eating smaller meals, avoiding high-fat foods, and staying well-hydrated.

Serious side effects are rare but require immediate medical attention: severe persistent abdominal pain may indicate pancreatitis, while symptoms of thyroid tumours (neck lump, hoarseness, difficulty swallowing) warrant urgent evaluation. Your prescriber will screen for contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 before prescribing.

Ongoing Treatment and Prescription Renewals

Weight management with Mounjaro is typically a long-term commitment rather than a short-term intervention. Clinical trials demonstrating efficacy followed patients for 72 weeks, and many individuals require ongoing treatment to maintain weight reduction achieved during active therapy [1][2].

Cured Pharmacy offers streamlined prescription renewal consultations for existing patients, allowing you to request continuation without repeating the full initial assessment. Your prescriber will review your progress, current weight trajectory, any side effects experienced, and whether dose adjustment is clinically indicated before approving refills.

If you decide to discontinue treatment, it's important to understand that weight regain is common following cessation of GLP-1 receptor agonists, as observed in extension phases of clinical trials [2]. Your prescriber can discuss strategies for maintaining weight loss through lifestyle modifications and whether transitioning to alternative maintenance therapies might be appropriate for your circumstances.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.